[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @StockwatchDK Stockwatch DK Stockwatch DK posts on X about cash flow, momentum, novo, eli lilly the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1955238286718341120/interactions)  - X Week XXX -XX% - X Month XXXXX +22% ### Mentions: XX [#](/creator/twitter::1955238286718341120/posts_active)  - X Week XX -XX% - X Month XXX +39% ### Followers: XX [#](/creator/twitter::1955238286718341120/followers)  - X Week XX +28% - X Month XX +52% ### CreatorRank: undefined [#](/creator/twitter::1955238286718341120/influencer_rank)  ### Social Influence [#](/creator/twitter::1955238286718341120/influence) --- **Social category influence** [currencies](/list/currencies) XXXXX% [finance](/list/finance) XXXXX% [stocks](/list/stocks) XXXX% **Social topic influence** [cash flow](/topic/cash-flow) 3.64%, [momentum](/topic/momentum) 1.82%, [novo](/topic/novo) #259, [eli lilly](/topic/eli-lilly) 1.82%, [eli](/topic/eli) 1.82%, [insurance](/topic/insurance) 1.82%, [bloomberg](/topic/bloomberg) 1.82%, [defence](/topic/defence) 1.82%, [targets](/topic/targets) 1.82%, [integration](/topic/integration) XXXX% **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/eli-lilly) ### Top Social Posts [#](/creator/twitter::1955238286718341120/posts) --- Top posts by engagements in the last XX hours "Nordea says momentum builds at Ambu and keeps Buy rating and target price of XXX DKK ahead of the Q4 2024/25 report" [X Link](https://x.com/StockwatchDK/status/1980567391966015912) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-21T09:30Z XX followers, XX engagements "Danske Bank upgrades Embla Medical to Hold from Sell and raises its 12M target price to DKK34 from DKK30 says Q3 results were solid with strong Prosthetics growth offset by weakness in Patient Care" [X Link](https://x.com/StockwatchDK/status/1980903983888875541) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-22T07:48Z XX followers, XX engagements "Danske Bank says that its estimate revisions and peer group valuations prompts it to increase its 12-month target price on ISS to DKK220 from DKK205. The bank reiterates Hold" [X Link](https://x.com/StockwatchDK/status/1980904777023189145) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-22T07:51Z XX followers, XX engagements "Danske Bank expects organic growth of XXX% y/y in Q3 XX an improvement on the XXX% reported for H1 XX. The bank slightly lowers its 2025 growth estimates while increasing its 2026 estimates cutting 2025E EBITA by XXX% and raising 2026E EBITA by 1.6%" [X Link](https://x.com/StockwatchDK/status/1980905122441097524) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-22T07:52Z XX followers, XX engagements "In a deep dive Danske Bank says that in Q4 XX Novo Nordisk will report data from the evoke and evoke+ trials where semaglutide is being tested for the treatment of early Alzheimers disease. -" [X Link](https://x.com/StockwatchDK/status/1970754633518981240) [@StockwatchDK](/creator/x/StockwatchDK) 2025-09-24T07:38Z XX followers, XXX engagements "Danske Bank believes Rockwools growth potential in the medium term is underappreciated by investors and consensus keeps Buy rating with a DKK XXX 12-month target price" [X Link](https://x.com/StockwatchDK/status/1975858464774639893) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-08T09:39Z XX followers, XX engagements "Says (1) Rockwool is adding 10+% new capacity in the next five years (2) there is a looming European rebound and (3) an underserved US market supporting volumes going forward. Danske Bank is on average X% above consensus on EBIT from 2027-29E" [X Link](https://x.com/StockwatchDK/status/1975858755410542805) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-08T09:40Z XX followers, XX engagements "Bernstein says M&A risk could overhang as pro-forma cliff steeper; Genmab will be pro-forma net cash in 2029; maintains Underperform with DKK1015 PT on 6x PE28 discount to peers" [X Link](https://x.com/StockwatchDK/status/1976207599209972121) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-09T08:46Z XX followers, XX engagements "rsted has concluded its DKK60bn rights issue and Danske Bank resumes coverage with a Buy rating and a target price of XXX DKK (vs XXX DKK earlier)" [X Link](https://x.com/StockwatchDK/status/1976222897284026403) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-09T09:47Z XX followers, XX engagements "Danske Bank expects rsted to announce farm-downs of Hornsea X and Greater Changhua X and see it capable of handling a worst-case scenario for Revolution and Sunrise Wind. There are still challenges to overcome but Danske Bank also sees value at current levels" [X Link](https://x.com/StockwatchDK/status/1976223008911130789) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-09T09:47Z XX followers, XX engagements "Says the DKK160 12M target price reflects both current construction risk and no future project wins. From 2028 onwards Danske Bank estimates an underlying annual free cash flow yield of 18%" [X Link](https://x.com/StockwatchDK/status/1976223347643122131) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-09T09:48Z XX followers, XX engagements "Handelsbanken is making a change to its sector favorites within Healthcare with Getinge becoming one of the sector favorites. Danish Genmab is Handelsbanken's first choice in the sector which means that Novo Nordisk is removed from the list after a return of XX percent" [X Link](https://x.com/StockwatchDK/status/1976566474316865959) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-10T08:32Z XX followers, XXX engagements "Handelsbanken continues to have a positive view on Novo Nordisk with a Buy recommendation but now sees greater risk-adjusted upside in Genmab and Getinge" [X Link](https://x.com/StockwatchDK/status/1976566657750651112) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-10T08:33Z XX followers, XXX engagements "Says on Genmab: Royalties for Darzalex will likely peak in 2028 and decline until 2031 when they will cease. With good visibility regarding Darzalex and given the tax rate of XX percent it is easy to reach a net present value after tax of approximately DKK 1000 per share" [X Link](https://x.com/StockwatchDK/status/1976566957337100795) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-10T08:34Z XX followers, XX engagements "Danske Bank downgrades DFDS to Sell from Hold and reduces the target price to XX DKK from XX DKK expects Q3 to be a weak quarter and says competition will make DFDS make a profit warning" [X Link](https://x.com/StockwatchDK/status/1976569255744115119) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-10T08:43Z XX followers, XX engagements "IQVIA new-to-brand (NBRx) trends for the starter doses of obesity GLP-1s in the US market for the week ending 3rd October: Total Novo Nordisk GLP-1 NBRx increased +8.5% w/w vs Eli Lilly increased +1.7% w/w (all doses)" [X Link](https://x.com/StockwatchDK/status/1977840341165498863) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-13T20:54Z XX followers, XX engagements "Danske Bank expects Lundbeck to either lift its guidance or narrow it to the upper end with the Q3 report driven by solid US scripts data for Vyepti and Rexulti that have exceeded our expectations" [X Link](https://x.com/StockwatchDK/status/1980235704237179141) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:32Z XX followers, XX engagements "Danske Bank awaits the next potential trigger for Alm Brand which is the CMD on XX November says expects continued repricing and improving claims trends to support underwriting while customer inflow in Privatsikring should drive continued solid double-digit growth in Private" [X Link](https://x.com/StockwatchDK/status/1980236332703359204) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:35Z XX followers, XX engagements "Says: We look for an XXXX% COR and a DKK527m insurance service result. Post PIM model approval solvency should jump to 240%. Danske reiterates Buy with a target of XX DKK" [X Link](https://x.com/StockwatchDK/status/1980236516728483897) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:35Z XX followers, XX engagements "Kepler Cheuvreux reiterates Hold and target price of XXX DKK on NKT ahead of the Q3 report on XX November. Following the increase in full-year guidance in connection with the Q2 report Kepler expects Q3 to show revenue growth of XXX percent entirely organic" [X Link](https://x.com/StockwatchDK/status/1980239953864147207) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:49Z XX followers, XX engagements "Kepler forecasts adjusted EBITDA of EUR XX million (Bloomberg consensus: EUR XX million) with a margin of XXXX percent (+10 basis points y/y). Free cash flow is expected to be EUR -XX million impacted by high investments" [X Link](https://x.com/StockwatchDK/status/1980240144729858053) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:50Z XX followers, XX engagements "Kepler says if its forecasts are confirmed NKT would be in line with or slightly above Keplers full-year EBITDA forecast of EUR XXX million for 2025 (company guidance: EUR 360-390 million corresponding to +5 percent to +13 percent y/y)" [X Link](https://x.com/StockwatchDK/status/1980240328008343989) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:50Z XX followers, XX engagements "SEB reiterates its Buy rating on Netcompany and raises the target price to DKK XXX (325). Netcompany will host its CMD on XX October where SEB's focus will be on 2030 financial targets SDC integration and the European defence sector potential" [X Link](https://x.com/StockwatchDK/status/1980242222332195167) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:58Z XX followers, XX engagements "Says: Factoring in the SDC acquisition our adj. EPS increases by 4-9% for 2026E-27E as we see significant EBIT margin improvement as a potential quick win. We continue to believe Netcompany is well positioned in the age of AI and reiterate our Buy rating" [X Link](https://x.com/StockwatchDK/status/1980242358227927097) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-20T11:59Z XX followers, XX engagements "For Q4 2024/25 Nordea expects organic revenue growth of XX% y/y which is XXX percentage points above analysts' expectations on average (before the capital markets day)" [X Link](https://x.com/StockwatchDK/status/1980567589479911521) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-21T09:31Z XX followers, X engagements "WindowMaster plans a 100-to-1 reverse share split requiring shareholder approval at an extraordinary general meeting. The reverse split aims to reduce share price volatility attract institutional investors and potentially facilitate a move to the main market the company says" [X Link](https://x.com/StockwatchDK/status/1980621092516512187) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-21T13:04Z XX followers, XX engagements "SEB has reinstated its Hold recommendation on rsted and updates its target price to DKK XXX post the rights issue continues to see the main risk in the investment case to be any adverse events which would trigger a downgrade of rsteds credit rating to sub-investment grade" [X Link](https://x.com/StockwatchDK/status/1980638759612973511) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-21T14:14Z XX followers, XX engagements "Commerzbank keeps Buy rating on Novo Nordisk after yesterday's news of an extraordinary general meeting on November XX 2025 to decide on a substantial reappointment of the Supervisory Board" [X Link](https://x.com/StockwatchDK/status/1980912379899834521) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-22T08:21Z XX followers, XX engagements "Nordea continues to recommend Buy on Embla Medical with a price target of DKK XXXX after the Q3 results says strong growth may prove to be sustainable as the acceleration appears to be partly driven by a strengthened product portfolio which has led to increased market share" [X Link](https://x.com/StockwatchDK/status/1980939348758741334) [@StockwatchDK](/creator/x/StockwatchDK) 2025-10-22T10:08Z XX followers, X engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@StockwatchDK Stockwatch DK
Stockwatch DK posts on X about cash flow, momentum, novo, eli lilly the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXX +22%
Mentions: XX #
- X Week XX -XX%
- X Month XXX +39%
Followers: XX #
- X Week XX +28%
- X Month XX +52%
CreatorRank: undefined #
Social Influence #
Social category influence currencies XXXXX% finance XXXXX% stocks XXXX%
Social topic influence cash flow 3.64%, momentum 1.82%, novo #259, eli lilly 1.82%, eli 1.82%, insurance 1.82%, bloomberg 1.82%, defence 1.82%, targets 1.82%, integration XXXX%
Top assets mentioned Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"Nordea says momentum builds at Ambu and keeps Buy rating and target price of XXX DKK ahead of the Q4 2024/25 report"
X Link @StockwatchDK 2025-10-21T09:30Z XX followers, XX engagements
"Danske Bank upgrades Embla Medical to Hold from Sell and raises its 12M target price to DKK34 from DKK30 says Q3 results were solid with strong Prosthetics growth offset by weakness in Patient Care"
X Link @StockwatchDK 2025-10-22T07:48Z XX followers, XX engagements
"Danske Bank says that its estimate revisions and peer group valuations prompts it to increase its 12-month target price on ISS to DKK220 from DKK205. The bank reiterates Hold"
X Link @StockwatchDK 2025-10-22T07:51Z XX followers, XX engagements
"Danske Bank expects organic growth of XXX% y/y in Q3 XX an improvement on the XXX% reported for H1 XX. The bank slightly lowers its 2025 growth estimates while increasing its 2026 estimates cutting 2025E EBITA by XXX% and raising 2026E EBITA by 1.6%"
X Link @StockwatchDK 2025-10-22T07:52Z XX followers, XX engagements
"In a deep dive Danske Bank says that in Q4 XX Novo Nordisk will report data from the evoke and evoke+ trials where semaglutide is being tested for the treatment of early Alzheimers disease. -"
X Link @StockwatchDK 2025-09-24T07:38Z XX followers, XXX engagements
"Danske Bank believes Rockwools growth potential in the medium term is underappreciated by investors and consensus keeps Buy rating with a DKK XXX 12-month target price"
X Link @StockwatchDK 2025-10-08T09:39Z XX followers, XX engagements
"Says (1) Rockwool is adding 10+% new capacity in the next five years (2) there is a looming European rebound and (3) an underserved US market supporting volumes going forward. Danske Bank is on average X% above consensus on EBIT from 2027-29E"
X Link @StockwatchDK 2025-10-08T09:40Z XX followers, XX engagements
"Bernstein says M&A risk could overhang as pro-forma cliff steeper; Genmab will be pro-forma net cash in 2029; maintains Underperform with DKK1015 PT on 6x PE28 discount to peers"
X Link @StockwatchDK 2025-10-09T08:46Z XX followers, XX engagements
"rsted has concluded its DKK60bn rights issue and Danske Bank resumes coverage with a Buy rating and a target price of XXX DKK (vs XXX DKK earlier)"
X Link @StockwatchDK 2025-10-09T09:47Z XX followers, XX engagements
"Danske Bank expects rsted to announce farm-downs of Hornsea X and Greater Changhua X and see it capable of handling a worst-case scenario for Revolution and Sunrise Wind. There are still challenges to overcome but Danske Bank also sees value at current levels"
X Link @StockwatchDK 2025-10-09T09:47Z XX followers, XX engagements
"Says the DKK160 12M target price reflects both current construction risk and no future project wins. From 2028 onwards Danske Bank estimates an underlying annual free cash flow yield of 18%"
X Link @StockwatchDK 2025-10-09T09:48Z XX followers, XX engagements
"Handelsbanken is making a change to its sector favorites within Healthcare with Getinge becoming one of the sector favorites. Danish Genmab is Handelsbanken's first choice in the sector which means that Novo Nordisk is removed from the list after a return of XX percent"
X Link @StockwatchDK 2025-10-10T08:32Z XX followers, XXX engagements
"Handelsbanken continues to have a positive view on Novo Nordisk with a Buy recommendation but now sees greater risk-adjusted upside in Genmab and Getinge"
X Link @StockwatchDK 2025-10-10T08:33Z XX followers, XXX engagements
"Says on Genmab: Royalties for Darzalex will likely peak in 2028 and decline until 2031 when they will cease. With good visibility regarding Darzalex and given the tax rate of XX percent it is easy to reach a net present value after tax of approximately DKK 1000 per share"
X Link @StockwatchDK 2025-10-10T08:34Z XX followers, XX engagements
"Danske Bank downgrades DFDS to Sell from Hold and reduces the target price to XX DKK from XX DKK expects Q3 to be a weak quarter and says competition will make DFDS make a profit warning"
X Link @StockwatchDK 2025-10-10T08:43Z XX followers, XX engagements
"IQVIA new-to-brand (NBRx) trends for the starter doses of obesity GLP-1s in the US market for the week ending 3rd October: Total Novo Nordisk GLP-1 NBRx increased +8.5% w/w vs Eli Lilly increased +1.7% w/w (all doses)"
X Link @StockwatchDK 2025-10-13T20:54Z XX followers, XX engagements
"Danske Bank expects Lundbeck to either lift its guidance or narrow it to the upper end with the Q3 report driven by solid US scripts data for Vyepti and Rexulti that have exceeded our expectations"
X Link @StockwatchDK 2025-10-20T11:32Z XX followers, XX engagements
"Danske Bank awaits the next potential trigger for Alm Brand which is the CMD on XX November says expects continued repricing and improving claims trends to support underwriting while customer inflow in Privatsikring should drive continued solid double-digit growth in Private"
X Link @StockwatchDK 2025-10-20T11:35Z XX followers, XX engagements
"Says: We look for an XXXX% COR and a DKK527m insurance service result. Post PIM model approval solvency should jump to 240%. Danske reiterates Buy with a target of XX DKK"
X Link @StockwatchDK 2025-10-20T11:35Z XX followers, XX engagements
"Kepler Cheuvreux reiterates Hold and target price of XXX DKK on NKT ahead of the Q3 report on XX November. Following the increase in full-year guidance in connection with the Q2 report Kepler expects Q3 to show revenue growth of XXX percent entirely organic"
X Link @StockwatchDK 2025-10-20T11:49Z XX followers, XX engagements
"Kepler forecasts adjusted EBITDA of EUR XX million (Bloomberg consensus: EUR XX million) with a margin of XXXX percent (+10 basis points y/y). Free cash flow is expected to be EUR -XX million impacted by high investments"
X Link @StockwatchDK 2025-10-20T11:50Z XX followers, XX engagements
"Kepler says if its forecasts are confirmed NKT would be in line with or slightly above Keplers full-year EBITDA forecast of EUR XXX million for 2025 (company guidance: EUR 360-390 million corresponding to +5 percent to +13 percent y/y)"
X Link @StockwatchDK 2025-10-20T11:50Z XX followers, XX engagements
"SEB reiterates its Buy rating on Netcompany and raises the target price to DKK XXX (325). Netcompany will host its CMD on XX October where SEB's focus will be on 2030 financial targets SDC integration and the European defence sector potential"
X Link @StockwatchDK 2025-10-20T11:58Z XX followers, XX engagements
"Says: Factoring in the SDC acquisition our adj. EPS increases by 4-9% for 2026E-27E as we see significant EBIT margin improvement as a potential quick win. We continue to believe Netcompany is well positioned in the age of AI and reiterate our Buy rating"
X Link @StockwatchDK 2025-10-20T11:59Z XX followers, XX engagements
"For Q4 2024/25 Nordea expects organic revenue growth of XX% y/y which is XXX percentage points above analysts' expectations on average (before the capital markets day)"
X Link @StockwatchDK 2025-10-21T09:31Z XX followers, X engagements
"WindowMaster plans a 100-to-1 reverse share split requiring shareholder approval at an extraordinary general meeting. The reverse split aims to reduce share price volatility attract institutional investors and potentially facilitate a move to the main market the company says"
X Link @StockwatchDK 2025-10-21T13:04Z XX followers, XX engagements
"SEB has reinstated its Hold recommendation on rsted and updates its target price to DKK XXX post the rights issue continues to see the main risk in the investment case to be any adverse events which would trigger a downgrade of rsteds credit rating to sub-investment grade"
X Link @StockwatchDK 2025-10-21T14:14Z XX followers, XX engagements
"Commerzbank keeps Buy rating on Novo Nordisk after yesterday's news of an extraordinary general meeting on November XX 2025 to decide on a substantial reappointment of the Supervisory Board"
X Link @StockwatchDK 2025-10-22T08:21Z XX followers, XX engagements
"Nordea continues to recommend Buy on Embla Medical with a price target of DKK XXXX after the Q3 results says strong growth may prove to be sustainable as the acceleration appears to be partly driven by a strengthened product portfolio which has led to increased market share"
X Link @StockwatchDK 2025-10-22T10:08Z XX followers, X engagements